Indirect via Microbiota Modulation

Indirect via Microbiota Modulation refers to the alteration of disease processes or improvement of health not by targeting a specific molecular entity, but by modulating the composition or function of the host’s microbiota (the community of microorganisms such as bacteria, fungi, and viruses residing within the body, primarily the gut). Interventions include dietary modulation, administration of probiotics or prebiotics, antibiotics, and fecal microbiota transplantation (FMT). These approaches seek to correct dysbiosis (microbial imbalance), enhance host immunity, modulate metabolism, or suppress pathogens. The concept has therapeutic relevance in diverse conditions, including infections (notably Clostridium difficile), inflammatory and metabolic diseases, autoimmune conditions, and some cancers. However, as a “target,” it is not a classical molecule or protein, but rather a complex, dynamic ecological system, which means it does not fit standard drug target frameworks and comes with unique safety, regulatory, and mechanistic challenges.

Other names

Microbiota modulationMicrobiome-targeted therapyGut microbiota modulationFecal microbiota transplantation (as a class of intervention, not a target)Probiotic interventionPrebiotic intervention

Correction of dysbiosis by restoring microbial composition; Modulation of the host immune system (e.g., promoting Treg cell differentiation, anti-inflammatory cytokine production); Enhancement of gut barrier function; Production or augmentation of beneficial metabolic products (e.g., short-chain fatty acids); Suppression of pathogenic microbes by competitive exclusion or direct antimicrobial effect